Search
Check Out Our Sponsors
Latest topics
A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
+5
tonyj
despacio
mphatesmpb
abc123
CausticSymmetry
9 posters
Page 1 of 1
A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
J Am Acad Dermatol. 2011 Aug 27.
A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
Blume-Peytavi U, Lönnfors S, Hillmann K, Bartels NG.
Department of Dermatology and Allergy, Clinical Research Center for Hair and Skin Science, Charité-Universitätsmedizin Berlin, Berlin, Germany.
BACKGROUND:
Latanoprost is a prostaglandin analogue used to treat glaucoma. It can cause adverse effects, such as iridial and periocular hyperpigmentation, and eyelash changes including pigmentation and increased thickness, length, and number. Latanoprost has been used to treat eyelash alopecia, but knowledge on its effects on human scalp hair growth is not available.
OBJECTIVE:
The primary objectives were to assess the efficacy of latanoprost on hair growth and pigmentation. The secondary objectives were to assess the effect on scalp pigmentation; investigate the treatment duration needed to affect hair growth, hair pigmentation, and scalp pigmentation; and assess safety of latanoprost.
METHODS:
Sixteen men with mild androgenetic alopecia (Hamilton II-III) were included. Latanoprost 0.1% and placebo were applied daily for 24 weeks on two minizones on the scalp. Measurements on hair growth, density, diameter, pigmentation, and anagen/telogen ratio were performed throughout the study.
RESULTS:
At 24 weeks, an increased hair density on the latanoprost-treated site was observed compared with baseline (n = 16, P < .001) and placebo-treated site (P = .0004).
LIMITATIONS:
Only young men with mild androgenetic alopecia were included. The results may not be applicable to other patient groups. Choice of investigational site may have affected the results.
CONCLUSIONS:
Latanoprost significantly increased hair density (terminal and vellus hairs) at 24 weeks compared with baseline and the placebo-treated area. Latanoprost could be useful in stimulating hair follicle activity and treating hair loss.
A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
Blume-Peytavi U, Lönnfors S, Hillmann K, Bartels NG.
Department of Dermatology and Allergy, Clinical Research Center for Hair and Skin Science, Charité-Universitätsmedizin Berlin, Berlin, Germany.
BACKGROUND:
Latanoprost is a prostaglandin analogue used to treat glaucoma. It can cause adverse effects, such as iridial and periocular hyperpigmentation, and eyelash changes including pigmentation and increased thickness, length, and number. Latanoprost has been used to treat eyelash alopecia, but knowledge on its effects on human scalp hair growth is not available.
OBJECTIVE:
The primary objectives were to assess the efficacy of latanoprost on hair growth and pigmentation. The secondary objectives were to assess the effect on scalp pigmentation; investigate the treatment duration needed to affect hair growth, hair pigmentation, and scalp pigmentation; and assess safety of latanoprost.
METHODS:
Sixteen men with mild androgenetic alopecia (Hamilton II-III) were included. Latanoprost 0.1% and placebo were applied daily for 24 weeks on two minizones on the scalp. Measurements on hair growth, density, diameter, pigmentation, and anagen/telogen ratio were performed throughout the study.
RESULTS:
At 24 weeks, an increased hair density on the latanoprost-treated site was observed compared with baseline (n = 16, P < .001) and placebo-treated site (P = .0004).
LIMITATIONS:
Only young men with mild androgenetic alopecia were included. The results may not be applicable to other patient groups. Choice of investigational site may have affected the results.
CONCLUSIONS:
Latanoprost significantly increased hair density (terminal and vellus hairs) at 24 weeks compared with baseline and the placebo-treated area. Latanoprost could be useful in stimulating hair follicle activity and treating hair loss.
_________________
My regimen
http://www.immortalhair.org/mpb-regimen
Now available for consultation (hair and/or health)
http://www.immortalhair.org/health-consultation
Re: A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
How do you get this in a topical? Is it safe?
abc123- Posts : 1128
Join date : 2010-07-31
Re: A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
Another older post on it:
https://immortalhair.forumotion.com/t590-bimatoprost
As a side note, a by product of urine can reduce glaucoma, more info on this here:
http://www.immortalhair.org/apps/blog/show/1835795-prevent-blindness-age-related-vision-loss-part-3
This whole thing with hair loss in my opinion is a combination of thyroid and adrenal balance.
https://immortalhair.forumotion.com/t590-bimatoprost
As a side note, a by product of urine can reduce glaucoma, more info on this here:
http://www.immortalhair.org/apps/blog/show/1835795-prevent-blindness-age-related-vision-loss-part-3
This whole thing with hair loss in my opinion is a combination of thyroid and adrenal balance.
_________________
My regimen
http://www.immortalhair.org/mpb-regimen
Now available for consultation (hair and/or health)
http://www.immortalhair.org/health-consultation
Xalatan
I work in a pharmacy. This stuff flies off the shelf. Not for hair growth though Interesting article. Thanks CS.
despacio- Posts : 24
Join date : 2011-09-03
Re: A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
Is this like minoxidil when you stop applying the topical you loose what you gained you're back to baseline?
tonyj- Posts : 390
Join date : 2009-10-03
Re: A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
The effects last longer than those of minoxidil.
...In reviewing the records and photographs of 89 glaucoma patients with hypertrichosis following unilateral treatment with topical latanoprost, he found five patients who had been treated for only a brief interval (less than 3 weeks) who showed increased number, length, thickness, and pigmentation of lashes similar to others who had undergone sustained treatment. Furthermore, these changes persisted in varying degrees for up to 14 months, the duration of the followup interval.
mphatesmpb- Posts : 621
Join date : 2010-10-21
Re: A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
I think the problem will be the same as with minox: it doesnt interferes with the basic mechanism of hairloss, it only set ups some kind of 'extra' baseline.
cyclonus- Posts : 18
Join date : 2011-04-18
Re: A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
How do we get this? and is it safe?
helpmyhair1- Posts : 445
Join date : 2009-10-20
Re: A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
abc123 wrote:How do you get this in a topical? Is it safe?
It comes ready in an eyedrop solution for people with glaucoma. I belive the medication is called Xalatan.
My father has glaucoma and uses it. I can probably get a bottle from him and try it out.
How would I use it though?
bh2o- Posts : 293
Join date : 2011-06-21
Re: A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
I think the problem will be the same as with minox: it doesnt interferes with the basic mechanism of hairloss, it only set ups some kind of 'extra' baseline.
I don't think there's an atomic solution to hair loss because hair loss is a multifactorial problem. So anything in your regimen that pushes you in the right direction (ie., keeps hair follicles in anagen phase) contributes to success. There are probably thousands of things that can do this, some more effectively than others.
There's no way to know for sure. But latanaprost is an analog of a certain prostaglandin, and prostaglandins are enzymatically derived from fatty acids. So it seems like it's at least "natural" in some sense. Whatever 'natural' means nowadays, lol.
How do we get this? and is it safe?
mphatesmpb- Posts : 621
Join date : 2010-10-21
Re: A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
Latanoprost 0.1% and placebo were applied daily for 24 weeks on two minizones on the scalp.
So I guess once a day in the area you want results. My only problem, other than curiosities about the discoloration for people without dark hair, is that latanoprost used for glaucoma is .005%. People do see results with their eyelashes at that percent but I'm not crazy about trying it for six months at 1/20 the strength to find underwhelming results.
runnerup- Posts : 68
Join date : 2011-07-13
Similar topics
» Safety and Efficacy of Rice Bran Supercritical CO2 Extract for Hair Growth in Androgenic Alopecia: A 16-Week Double-Blind Randomized Controlled Trial.
» A 3-month, randomized, double-blind, placebo-controlled study evaluating the ability of an extra-strength marine protein supplement to promote hair growth and decrease shedding in women with self-perceived thinning hair.
» A 3-month, randomized, double-blind, placebo-controlled study evaluating the ability of an extra-strength marine protein supplement to promote hair growth and decrease shedding in women with self-perceived thinning hair.
» A Double-blind, Placebo-controlled Study Evaluating the Efficacy of an Oral Supplement in Women with Self-perceived Thinning Hair
» Effect of a sphingolipid-mimetic compound on the promotion of hair growth: A randomized, double-blind, placebo-controlled clinical trial
» A 3-month, randomized, double-blind, placebo-controlled study evaluating the ability of an extra-strength marine protein supplement to promote hair growth and decrease shedding in women with self-perceived thinning hair.
» A 3-month, randomized, double-blind, placebo-controlled study evaluating the ability of an extra-strength marine protein supplement to promote hair growth and decrease shedding in women with self-perceived thinning hair.
» A Double-blind, Placebo-controlled Study Evaluating the Efficacy of an Oral Supplement in Women with Self-perceived Thinning Hair
» Effect of a sphingolipid-mimetic compound on the promotion of hair growth: A randomized, double-blind, placebo-controlled clinical trial
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
|
|
Yesterday at 4:00 pm by CausticSymmetry
» *The first scientific evidence in 2021 that viruses do not exist*
Fri Apr 26, 2024 12:44 pm by CausticSymmetry
» Potential Natural Products Regulation of Molecular Signaling Pathway in Dermal Papilla Stem Cells
Wed Apr 17, 2024 7:44 am by CausticSymmetry
» Breast Biopsy
Sun Apr 14, 2024 2:23 am by shaftless
» Sorry if brought up before but: Best topical to help aid in breaking up fibrosis?
Sat Apr 13, 2024 2:51 am by Hoppipolla
» solar eclipse on april 8
Thu Apr 11, 2024 4:04 am by shaftless
» Role and Mechanisms of Phytochemicals in Hair Growth and Health
Wed Apr 10, 2024 4:20 am by CausticSymmetry
» IH Regimen
Tue Apr 09, 2024 4:25 pm by CF
» Exosome Theory and Herpes
Mon Apr 08, 2024 11:16 am by MikeGore